Medicare Enrolled
Dr. Bernard Gran, M.D.
Neurology · Miami, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gran?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gran
Dr. Bernard Gran is a neurology specialist in Miami, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gran performed 793 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Gran received a total of $18,691 from 87 pharmaceutical and/or device companies across 886 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 37% volume in FL
$18,691 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 30639 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗793
Medicare services
Top 37% in FL for neurology
Not available
Unique patients (not deduplicated)
$107
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
327 | $101 | $562 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
92 | $90 | $467 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
63 | $68 | $312 |
| Annual depression screening | 60 | $19 | $77 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
46 | $148 | $870 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
40 | $111 | $596 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
33 | $127 | $730 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
27 | $311 | $1,599 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
27 | $110 | $607 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
26 | $103 | $449 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
15 | $142 | $788 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
13 | $176 | $960 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
12 | $146 | $803 |
| New patient office visit, complex (60-74 min) | 12 | $169 | $976 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$18,691
Total received (2018-2024)
Avg $2,670/year across 7 years
Top 17% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
87
Companies
886
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,222
2023
$3,409
2022
$2,231
2021
$2,963
2020
$2,294
2019
$2,421
2018
$2,151
Payments by company (2024)
UCB, Inc.
$791
ABBVIE INC.
$523
Neurocrine Biosciences, Inc.
$205
Eisai Inc.
$186
Novartis Pharmaceuticals Corporation
$166
Teva Pharmaceuticals USA, Inc.
$134
PFIZER INC.
$112
Amgen Inc.
$98
Lilly USA, LLC
$94
Mallinckrodt Hospital Products Inc.
$92
MITSUBISHI TANABE PHARMA AMERICA, INC.
$87
Axsome Therapeutics, Inc.
$86
AstraZeneca Pharmaceuticals LP
$71
BANNER LIFE SCIENCES, LLC
$55
Celgene Corporation
$52
ARGENX US, INC.
$51
Harmony Biosciences Llc
$50
Lundbeck LLC
$48
JAZZ PHARMACEUTICALS INC.
$48
Otsuka America Pharmaceutical, Inc.
$45
Amneal Pharmaceuticals LLC
$39
Takeda Pharmaceuticals U.S.A., Inc.
$31
SCILEX PHARMACEUTICALS INC.
$25
Marinus Pharmaceuticals, Inc.
$25
Neurelis, Inc.
$24
Octapharma USA, Inc.
$23
Kyowa Kirin, Inc.
$23
TG Therapeutics, Inc.
$22
Acorda Therapeutics, Inc
$20
Top 3 companies account for 47.2% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$3,969
ABBVIE INC.
$1,454
Amgen Inc.
$1,336
Teva Pharmaceuticals USA, Inc.
$1,251
Neurocrine Biosciences, Inc.
$839
Adamas Pharmaceuticals, Inc.
$643
Lilly USA, LLC
$548
Novartis Pharmaceuticals Corporation
$495
Acorda Therapeutics, Inc
$389
Eisai Inc.
$383
Almatica Pharma LLC
$371
Mitsubishi Tanabe Pharma America, Inc.
$277
SK Life Science, Inc.
$263
Alexion Pharmaceuticals, Inc.
$260
Biohaven Pharmaceuticals, Inc.
$237
Sunovion Pharmaceuticals Inc.
$229
JAZZ PHARMACEUTICALS INC.
$228
Allergan Inc.
$218
Mallinckrodt Hospital Products Inc.
$210
MITSUBISHI TANABE PHARMA AMERICA, INC.
$207
Abbott Laboratories
$205
PFIZER INC.
$198
AbbVie Inc.
$188
Lundbeck LLC
$187
Neurelis, Inc.
$186
Genentech USA, Inc.
$171
EISAI INC.
$161
Upsher-Smith Laboratories LLC
$159
Allergan, Inc.
$150
Grifols USA, LLC
$145
Biohaven Pharmaceutical Holding Company Ltd.
$144
Otsuka America Pharmaceutical, Inc.
$142
Biogen, Inc.
$137
AstraZeneca Pharmaceuticals LP
$133
Harmony Biosciences LLC
$117
ARGENX US, INC.
$113
AQUESTIVE THERAPEUTICS, INC.
$112
Kyowa Kirin, Inc.
$110
Janssen Pharmaceuticals, Inc
$100
US WorldMeds, LLC
$98
ACADIA Pharmaceuticals Inc
$98
Axsome Therapeutics, Inc.
$86
Celgene Corporation
$84
Boston Scientific Corporation
$83
HARMONY BIOSCIENCES LLC
$74
BANNER LIFE SCIENCES, LLC
$71
EMD Serono, Inc.
$71
Greenwich Biosciences, Inc.
$69
Octapharma USA, Inc.
$65
GENZYME CORPORATION
$62
Averitas Pharma Inc.
$62
LivaNova USA, Inc.
$59
Horizon Therapeutics plc
$56
TG THERAPEUTICS, INC.
$55
Zyla Life Sciences
$55
Aprecia Pharmaceuticals, LLC
$55
Harmony Biosciences Llc
$50
Takeda Pharmaceuticals U.S.A., Inc.
$48
CSL Behring
$47
Bausch Health US, LLC
$45
Avanir Pharmaceuticals, Inc.
$41
GE HealthCare
$41
Amneal Pharmaceuticals LLC
$39
Promius Pharma LLC
$34
Philips Electronics North America Corporation
$30
E.R. Squibb & Sons, L.L.C.
$29
Merz Pharmaceuticals, LLC
$28
Piramal Imaging Limited
$27
SCILEX PHARMACEUTICALS INC.
$25
GE HEALTHCARE
$25
Marinus Pharmaceuticals, Inc.
$25
AbbVie, Inc.
$25
Currax Pharmaceuticals LLC
$23
IMPEL PHARMACEUTICALS INC.
$23
TG Therapeutics, Inc.
$22
Alfasigma USA, Inc.
$21
Supernus Pharmaceuticals, Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$20
Avion Pharmaceuticals
$19
Catalyst Pharmaceuticals, Inc.
$19
ARBOR PHARMACEUTICALS, INC.
$17
Akcea Therapeutics, Inc.
$17
Vanda Pharmaceuticals Inc.
$17
Vertical Pharmaceuticals, LLC
$15
ASSERTIO THERAPEUTICS, Inc.
$14
Neuronetics, Inc.
$11
Bardy Diagnostics, Inc.
$10
Top 3 companies account for 36.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · COMIRNATY · CONTRAVE · COPAXONE · Cambia · Carnation Ambulatory Monitor · DUOPA · Dhivy · Duopa · EMGALITY · EPIDIOLEX · EVUSHELD · Epidiolex · FYCOMPA · Fabhalta · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · General - DBS · HETLIOZ · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · Leqembi · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NEURACEQ · NEUROSTAR TMS THERAPY · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS 50MG CAPSULES 30 · OSMOLEX ER · Ocrevus · Ongentys · PANZYGA · PAXLOVID · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPRIX · SYMPAZAN · Soliris · Spritam · Sunosi · TEGSEDI · TOPIRAMATE Extended Release Capsules · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS Therapy · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · WATCHMAN FLX · Wakix · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZTALMY · ZTLido · Zembrace · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
220
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
BAPTIST HOSPITAL OF MIAMI
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gran is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gran experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gran performed 327 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gran receive payments from pharmaceutical companies?
Yes. Dr. Gran received a total of $18,691 from 87 companies across 886 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gran's costs compare to other neurologists in Miami?
Dr. Gran's average Medicare payment per service is $107. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Miami
Browse neurologists in Miami ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology